Forty-seven HSA adducts were quantified by mass spectrometry, nine of which were selected for association with lung cancer, including Cys34 sulfoxidation products and disulfides of cysteine and homocysteine and two modifications to Lys525. The gene discussed is ALB; the disease is lung carcinoma.